Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
about
Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labourOpioid Drugs in Patients With Liver Disease: A Systematic ReviewSplit liver transplantation: What's unique?The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleOccurrence of silk stitch abscess after surgery in patients with oral squamous cell carcinomaEvidence and consensus recommendations for the pharmacological management of pain in India.Review article: prescribing medications in patients with cirrhosis - a practical guide.Population Pharmacokinetics of Fentanyl in the Critically IllEffects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial.Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control.Minimally invasive Swine experimental model for the in vivo study of liver metabolism of drugs.Analgesia for the cirrhotic patient: a literature review and recommendations.Some considerations on the predictions of pharmacokinetic alterations in subjects with liver disease.Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.Development and initial testing of a tailored telephone intervention delivered by peers to prevent recurring opioid-overdoses (TTIP-PRO).A Survey of Knowledge and Attitudes of Nurses About Pain Management in End-Stage Liver Disease in a Geriatric Palliative Care Unit.Cardiopulmonary Bypass Ischemic Hepatitis Reported in Five Patients.Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.European Pain Federation position paper on appropriate opioid use in chronic pain management.Opioid misuse in gastroenterology and non-opioid management of abdominal pain.Effect of Transcranial Direct Current Stimulation of the Motor Cortex on Visceral Pain in Patients with Hepatocellular Carcinoma.The safety of combined sedation with propofol plus fentanyl for endoscopy screening and endoscopic variceal ligation in cirrhotic patients.The assessment and management of pain in cirrhosis.Morphine versus fentanyl patient-controlled analgesia for postoperative pain control in major hepatic resection surgeries including living liver donors: A retrospective study.Cancer Pain Management: Opioid Analgesics, Part 2
P2860
Q24187501-A934D628-5EC7-41E9-94AB-88C2EAFA7D91Q26743429-D89018EF-6644-43DD-88AC-C9A34D8ED45BQ26784104-F3A27D3E-8857-4F40-BAB9-C4ED353141DEQ28075382-9ACDA275-69A8-4BFC-A610-B9C6675817B5Q30451255-4381CFCC-5542-4A80-BE77-A0F3466F32EFQ30844805-4BF4B8B5-0354-4A99-9289-F9FC2024F1D8Q34342554-4584047C-3B1B-4CBA-AB2E-AD6226BEFB44Q36586522-8F892489-6484-4FC4-83B0-E6478F8BC06FQ36736306-B4EC1D48-8CA7-4C8E-BBAB-C7A850806F4AQ38077182-B07D9D38-A86B-4679-9000-A486F083F65CQ38125688-BFB63645-D96A-4679-8BC1-069666D1A8FEQ38189124-52FBE22B-7558-416B-A89A-613A16DCBBAFQ38248974-5C4C7F17-82F5-4963-8B08-FD8848EFFE57Q38730748-239AB2C8-1EA9-4F21-AF52-7017607E2BECQ38891489-319E726E-B548-4B16-B87F-CEF9CDF1882DQ38931223-F89533B5-6EB2-4A15-B399-BDE3FB43C67AQ39184019-97623770-E119-42F8-9DFB-67B025C35898Q41151476-F6EAC544-9DCC-40F4-B5B9-40BE4BAD5157Q44342097-E74BBC9B-CFD9-48CA-B2A0-CAEA5E49CEE0Q44350905-74AED847-4A94-473E-BA46-B9657A17F795Q47286399-382367F6-90C0-4703-8903-33BE4A46AA2BQ47950644-25CDB0B0-E3A8-4C20-B69A-7088C8E00949Q52351014-A1E38350-6807-4C8D-B171-4A3D01E34958Q52599741-EBE02D38-655D-4A12-B65E-6374F5E47687Q57498749-39146DBD-8836-43D5-B7CC-78CB970F0C21
P2860
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@en
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@nl
type
label
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@en
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@nl
prefLabel
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@en
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@nl
P2093
P2860
P1433
P1476
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
@en
P2093
Bernhard Walder
Jules Desmeules
Marie Besson
Marija Bosilkovska
Youssef Daali
P2860
P304
P356
10.2165/11635500-000000000-00000
P577
2012-08-01T00:00:00Z
P6179
1023502475